Caricamento...
Novel Approaches to Treatment of “Double-Refractory” Multiple Myeloma
Multiple myeloma refractory to both proteasome inhibitors and immunomodulatory agents (IMiDs) has a poor prognosis. With the increasing use of these agents as part of initial therapy, and then in the maintenance setting until disease progression, such drug resistance is an emerging problem of great...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2013
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3762449/ https://ncbi.nlm.nih.gov/pubmed/23714530 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EdBook_AM.2013.33.e302 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|